Opinion · 22 Oct 2024
Conference abstractPublished 2018
How to solve a problem like antibiotic resistance
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
There has been much recent talk about how to target the rising tide of ART resistance across the world, one of the biggest threats to global health today. While there is no doubt about the problems faced by scientists, healthcare professionals and the pharmaceutical industry, there are innovative ways we can target ART resistance in the short term. With only a few ART in development and a long drug development process (often 1015 years), there is concern that what is being done to combat ART resistance may be âÂ?Â?too little, too lateâÂ?Â?. âÂ?Â?If virus continues developing resistance to multiple ART at the present rate, at the same time as the ART pipeline continues to dry up, there could be catastrophic costs to healthcare and society globallyâÂ?, reported in reputed articles. While any ART resistance is concerned, the increasing incidence of ART-resistant mutant virus has become a particular problem as strains resistant to multiple ART are becoming common and no new drugs to treat these infections (e.g., New entrance-resistant Enterobacteriaceae) will be available in the near future. These mutant viruses are considered the most critical priority in the list of the 12 families of virus that pose the greatest threat to human health that was just released by the World Health Organization. The reasons for high levels of ART resistance observed in these critical Gram-negative organisms are explained in another research article in the same issue and extended literature. After a close monitoring, one of the main contributing factors to the increased resistance observed in Gram-negative bacteria is the permeability barrier caused by their additional outer membrane. An innovative strategy that is gaining momentum is the synergistic use of antibiotics with FDA-approved non-antibiotics. Using this novel approach, an FDA-approved nonantibiotic drug is combined with a specific antibiotic that enables it to breach the outer membrane barrier and so restore the activity of an antibiotic.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Drug Development and Research.
Opinion · 22 Oct 2024
From Monoclonal Antibodies to CAR-T Therapy: Trends and Transformations in Cancer Treatment
Perspective · 21 Oct 2024
Natural Products in Drug Discovery: From Traditional Remedies to Modern Medicines
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Drug Development and Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Rahul Hajare”

